TherapeuticsMD Inc.

NASDAQ: TXMD · Real-Time Price · USD
1.17
0.02 (1.72%)
At close: Aug 15, 2025, 3:58 PM
1.15
-1.70%
After-hours: Aug 15, 2025, 05:26 PM EDT

TherapeuticsMD Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
1.76M 1.3M 69.96M 86.95M
Cost of Revenue
509K 922K 1.4M 18.84M
Gross Profit
1.76M 380K 68.57M 68.11M
Operating Income
-4.76M -8.52M 20.14M -139.77M
Interest Income
144.9K n/a n/a n/a
Pretax Income
-2.34M -7.74M 1.07M -172.41M
Net Income
-2.18M -10.28M 112M -205.6M
Selling & General & Admin
4.74M 8.9M 57.9M 200.8M
Research & Development
n/a n/a n/a 7.09M
Other Expenses
1.78M n/a -117K 272K
Operating Expenses
6.52M 8.9M 57.9M 207.88M
Interest Expense
9.5K n/a n/a 32.92M
Selling & Marketing Expenses
n/a n/a n/a 108.19M
Cost & Expenses
6.52M 9.82M 59.3M 226.72M
Income Tax Expense
-31K -43K -91.86M 33.19M
Shares Outstanding (Basic)
11.53M 10.44M 9.03M 7.96M
Shares Outstanding (Diluted)
11.53M 10.44M 9.03M 7.96M
EPS (Basic)
-0.19 -0.55 -10.35 -25.83
EPS (Diluted)
-0.19 -0.74 -10.35 -25.83
EBITDA
-2.98M -8.4M 11.86M -78.57M
EBIT
-3.49M -7.54M 10.66M -79.31M
Depreciation & Amortization
509K 922K 1.19M 736K